0
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Synthetic Retinoids Improve Survival in Rodent Model of Endotoxic Shock

, , &
Pages 165-169 | Received 01 Sep 2001, Published online: 04 Dec 2011
 

Abstract

Objective- To investigate the effect of synthetic retinoids on septic shock induced by lipopolysaccharide (LPS) in rats

Design- Randomised study

Settings- University hospital laboratory, Sweden

Animals and interventions- 31 male Sprague Dawley rats randomised into four groups: controls, given vehicle alone (n = 6), LPS 6 mg/kg body weight alone (n = 12), and LPS 6mg/kg but pretreated with the retinoic acid receptor-α (RAR-α) agonists CD336 (n = 6) and CD2081 (n = 7).

Main outcome measures- Arterial blood pressure and heart rate measured hourly for four hours; mortality.

Results- LPS caused a pronounced fall in blood pressure within one hour of injection in all groups of rats. Of the 12 rats given LPS but not RAR-α agonists, 6 died before the end of the experiment. By contrast, all animal given either CD336 or CD2081 survived. The significantly improved survival was found despite no significant improvements in either mean arterial pressure or heart rate.

Conclusion- Pretreatment with selective synthetic RAR-α agonists improves survival after LPS-induced septic shock in rats. These agents may have therapeutic potential in the treatment of septic shock in humens.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.